| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/08/2007 | US20070031823 Bioinformatically detectable group of novel vaccinia regulatory genes and uses thereof |
| 02/08/2007 | US20070031478 Modified peptides and their uses |
| 02/08/2007 | US20070031453 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/08/2007 | US20070031444 Compounds targeted to cellular locations |
| 02/08/2007 | US20070031442 Method and compositions for boosting immune response |
| 02/08/2007 | US20070031440 Modified transferin-antibody fusion proteins |
| 02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 02/08/2007 | US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens |
| 02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
| 02/08/2007 | US20070031414 DR5 antibodies and uses thereof |
| 02/08/2007 | US20070031410 POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use |
| 02/08/2007 | US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 02/08/2007 | US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy |
| 02/08/2007 | US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
| 02/08/2007 | US20070031336 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2625909A1 Development of pcr primers and primer mixtures for amplification of cnp60 target sequences |
| 02/08/2007 | CA2617792A1 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/08/2007 | CA2617561A1 Multivalent rna nanoparticles for delivery of active agents to a cell |
| 02/08/2007 | CA2616891A1 Hepatitis c antivirals |
| 02/08/2007 | CA2616601A1 Methylation markers for prognosis and treatment of cancers |
| 02/07/2007 | EP1749833A1 Super-antigens derived from the SARS coronavirus E2 spike protein |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749108A2 Nanoscale electronic detection system and methods for their manufacture |
| 02/07/2007 | EP1749107A2 Method for the taxon-specific identification of cells of gram-positive bacteria and devices for carrying out said method |
| 02/07/2007 | EP1748954A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/07/2007 | EP1748782A2 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 02/07/2007 | EP1706491A4 Toxin complex proteins and genes from xenorhabdus bovienii |
| 02/07/2007 | EP1620575A4 Method of electrochemical detection of somatic cell mutations |
| 02/07/2007 | EP1601785A4 Methods for detection of genetic disorders |
| 02/07/2007 | EP1599602A4 Predicting graft rejection |
| 02/07/2007 | EP1272609B1 Single chain antibody against mutant p53 |
| 02/07/2007 | CN1910294A Treatment strategies for immune-response disorders by using Fc receptor polymorphisms as diagnostics |
| 02/07/2007 | CN1910293A Detection of mutations in a gene associated with resistance to viral infection, OASI |
| 02/07/2007 | CN1910289A Primers and probes for the detection of hiv |
| 02/07/2007 | CN1910193A Ribonucleic acid compound and method of liquid-phase synthesis of oligonucleic acid compound |
| 02/07/2007 | CN1909922A Novel flavivirus antigens |
| 02/07/2007 | CN1908174A Method of producing L-lysine |
| 02/07/2007 | CN1908167A Method for synthesizing isothermal unidirectional growth gene |
| 02/07/2007 | CN1299117C Arrays of microparticles and methods of preparation thereof |
| 02/07/2007 | CN1298849C Device for housing/processing carrier and method for housing/processing carrier |
| 02/07/2007 | CN1298729C Modular peptide-based reagent |
| 02/06/2007 | US7173125 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/06/2007 | US7173124 Isolation of nucleic acid |
| 02/06/2007 | US7173123 Methods for detection of chloral hydrate in dichloroacetic acid |
| 02/06/2007 | US7173122 Antisense oligonucleotides to type I procollagen |
| 02/06/2007 | US7173121 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/06/2007 | US7173120 Regulatory sequences for regulation of gene expression in plants and other organisms, and compositions, products and methods related thereto |
| 02/06/2007 | US7173119 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual |
| 02/06/2007 | US7173118 Nogo receptor homologs |
| 02/06/2007 | US7173117 Codon optimised recombinant Dermaphagoides allergens |
| 02/06/2007 | US7173116 Nucleic acid formulations for gene delivery and methods of use |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173015 Inhibition of Syk kinase expression |
| 02/06/2007 | US7173014 For therapy of HIV infection |
| 02/06/2007 | US7173000 Modified factor VIIa |
| 02/06/2007 | US7172997 Having specific base substitutions and improved thermostability; controlling pitch troubles in pulping or papermaking; detergents; removing hydrophobic esters from fabrics; catalyst for hydrolysis or synthesis of esters |
| 02/06/2007 | US7172898 Not expressed in normal adult tissue, but is highly expressed in prostate tissue xenografts |
| 02/06/2007 | US7172896 Integrated portable biological detection system |
| 02/06/2007 | US7172894 Reductase gene and use of the same |
| 02/06/2007 | US7172890 Glucose dehydrogenase varient having less residual enzymatic activity relative to wild type; retains coenzyme binding; amino acid sequence with substitution mutation with fused segment capable of forming metal chelate; DNA sequences encoding oxidoreductase apoenzyme; gene expression and engineering |
| 02/06/2007 | US7172886 Biosynthesis of isopentenyl pyrophosphate |
| 02/06/2007 | US7172885 Thermostable omega-transaminases |
| 02/06/2007 | US7172865 Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors |
| 02/06/2007 | US7172864 Contacting biomolecule in solution with permeation layer at a microlocation;concentrating by placing electrode at an opposite charge; reacting restriction enzyme, ligase, proteinase, glycosidase, DNA or RNA polymerase or a phosphorylase with biomolecule; diagnosis; molecular hybridization |
| 02/06/2007 | US7172863 Oligonucleotide able to hybridize to Neisseria gonorrhoeae nucleic acid r RNA but not Neisseria meningitis; probes for Mycobacterium, Legionella, Salmonella, Chlamydia, Campylobacter, Proteus, Enterococcus, Enterobacter, Escherichia, and/or Pseudomonas |
| 02/06/2007 | US7172861 Activity-based assay for ricin-like toxins |
| 02/06/2007 | US7172750 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/06/2007 | CA2355292C Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces |
| 02/01/2007 | WO2007014370A2 Small regulatory rnas and methods of use |
| 02/01/2007 | WO2007014162A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 02/01/2007 | WO2007012494A1 Stable nad/nadh derivatives |
| 02/01/2007 | WO2007012285A1 Viral infection resistent single strand deoxynucleosides |
| 02/01/2007 | WO2006116260A3 Modulation of antibody effector function by hinge domain engineering |
| 02/01/2007 | WO2006087465A3 Method for preparing synthetic fragments of bicatenary nucleic acids |
| 02/01/2007 | WO2006083851A3 Method for detecting adverse reaction susceptibility to an hmg coa reductase inhibitor |
| 02/01/2007 | WO2006081158A3 Predictive and therapeutic markers in overian cancer |
| 02/01/2007 | WO2006053187B1 Device and method for purification of biological materials |
| 02/01/2007 | WO2006042137A3 Methods for identifying parkinson's disease therapeutics |
| 02/01/2007 | WO2006031745A3 Methods for long-range sequence analysis of nucleic acids |
| 02/01/2007 | WO2006028508A3 Methods and apparatus for characterizing polynucleotides |
| 02/01/2007 | WO2006023848A3 Rna interference vectors |
| 02/01/2007 | WO2006017854A3 Compositions and methods for determining and predicting treatment responses for depression and anxiety |
| 02/01/2007 | WO2006017206A3 Flavivirus vaccine |
| 02/01/2007 | WO2006007557A3 Ryegrass cbf3 gene : identification and isolation |
| 02/01/2007 | WO2006007411A3 Methods and compositions for modulating bax-mediated apoptosis |
| 02/01/2007 | WO2005079462A3 Methods and materials using signaling probes |
| 02/01/2007 | WO2005069854A3 Methods and materials relating to novel c1q domain-containing polypeptides and polynucleotides |
| 02/01/2007 | WO2005062959A3 Isolated t lymphocyte receptors specific for human autoantigens complexed with human mhc molecules and methods of making and using same |
| 02/01/2007 | WO2005026184A3 Synthesis and compositions of 2'-terminator nucleotides |
| 02/01/2007 | WO2004090501A3 Method for the surveillance for biological, chemical and radiological agents |